Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

Core Points - Amarin Corporation plans to change the ratio of its American Depositary Shares (ADS) from 1:1 to 1:20 to comply with Nasdaq's minimum bid price requirement of $1.00 per share [1][3] - The effective date for this ratio change is expected to be around April 11, 2025 [1] - The adjustment will not affect the ordinary shares of Amarin, and the ADSs will continue to trade under the symbol "AMRN" on The Nasdaq Capital Market [2] Summary by Sections Ratio Change Details - The ratio change aims to increase the per share market price of the Company's ADSs to maintain its listing on Nasdaq [3] - Holders of uncertificated ADSs will not need to take action as the exchange will occur automatically, while registered holders of certificated ADSs must surrender their shares for the new ratio [3][4] - No fractional new ADSs will be issued; instead, fractional entitlements will be aggregated and sold, with net cash proceeds distributed to ADS holders [4] Market Impact - The trading price of the Company's ADSs is expected to increase proportionally due to the ratio change, although there is no assurance that the price will be equal to or greater than twenty times the pre-adjustment price [5] Company Overview - Amarin is an innovative pharmaceutical company focused on cardiovascular disease management and aims to enhance the understanding and treatment of cardiovascular risks [6]